H2 Blockers for Pruritus Management

Evidence-Based Indications

The American Academy of Allergy, Asthma, and Immunology recommends combined H1 and H2 antihistamine therapy for pruritus in mast cell activation syndrome (MCAS) and mastocytosis 1, 2
The combination of H1 and H2 antagonists is more effective than either agent alone for controlling severe pruritus and wheal formation in mastocytosis 3, 4, 5
H2 blockers work prophylactically rather than acutely—they must be given before histamine is released to prevent receptor binding 1, 2
Cimetidine may resolve pruritus in patients with lymphoma-associated generalized pruritus (Strength of recommendation D) 6, 7
Cimetidine is listed among multiple agents that may relieve pruritus associated with polycythemia vera (Strength of recommendation D) 6, 7

The British Association of Dermatologists notes that H2 blockers with anticholinergic effects, such as cimetidine, can cause cognitive decline, especially in elderly populations 1, 2, 9
Famotidine may be preferred over cimetidine due to fewer anticholinergic effects 10

For mast cell disorders (MCAS, mastocytosis), the American Academy of Allergy, Asthma, and Immunology recommends starting H1 antihistamine and adding H2 blocker (famotidine 20-40 mg daily or ranitidine equivalent) for refractory symptoms 1, 2, 3, 4
For lymphoma or polycythemia vera-associated pruritus, consider cimetidine as part of multimodal therapy (Strength D) 6, 7
For generalized pruritus of unknown origin, only use H2 blockers in combination with H1 antihistamines, never alone 8
Avoid H2 blockers in elderly patients when possible due to cognitive decline risk; if necessary, choose famotidine over cimetidine 1, 2, 10